Dr Felix Dahm, MD

Co-founder & Managing Partner

Instrumental in EUR >15 Billion of realized Private Equity transaction value over the course of his career.

Expert in realizing the massive commercial potential of Life Sciences companies through enhancing their scientific & clinical capabilities and operations and enabling value realization via strategic exits.

Life Sciences entrepreneur and M&A practitioner focused on buying and improving European Life Sciences investments, including those backed by one of the world’s largest financial investors. Operational Management of portfolio companies of Nordic Capital, EQT, and Investor, focused on driving strategy, innovation, operational transformations, and exits.

Medical Doctor, Abdominal Surgeon and Postdoc at University Hospital Zurich (Switzerland).

MD from Johannes Gutenberg University Mainz, Germany. Rotations at MD Anderson Cancer Center, Houston (US), Duke University Medical Center, Durham (US) and Beth Israel Deaconess Medical Center, Boston (US).